Author:
Montaner Julio SG,Hogg Robert,Raboud Janet,Harrigan Richard,O'Shaughnessy Michael
Reference55 articles.
1. Prognosis in HIV-I infection predicted by the quantity of virus in plasma;Mellors;Science,1996
2. Plasma viral load and CD4* lymphocytes as prognostic markers of HIV-I infection;Mellors;Ann Intern Med,1997
3. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy;Gulick;N Engl J Med,1997
4. A randomised, double-blind trial comparing combinations of nevirapine, didanosine and zidovudine for HIV infected patients: the INCAS trial;Montaner;JAMA,1998
5. Gerstoft J, on behalf of the AVANTI Group. AVANTI 2: a randomised, double-blind, comparative trial to evaluate the efficacy, safety and tolerance of combination antiretroviral regimens for the treatment of HIV-I infection: AZT/3TC vs AZT/3TC/indinavir in antiretroviral naive patients. In: Proceedings of the International Congress on Antimicrobial Agents and Chemotherapy; September 1997:, Toronto (abstr 1-87).
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献